Olena Gennadiivna Aliyeva

Mrs. Olena Gennadiivna Aliyeva

Department of Histology, Cytology and Embryology, Zaporizhzhia State Medical and Pharmaceutical University, Zaporizhzhia, Zaporiz’ka Oblast’, Ukraine
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2023 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
IBIgor F. Belenichev
Igor F. Belenichev
Olena Gennadiivna AliyevaOlena Gennadiivna Aliyeva
Olena Gennadiivna Aliyeva
OPOlena O. Popazova
Olena O. Popazova
NBNina V. Bukhtiyarova
Nina V. Bukhtiyarova
This analytical review summarizes literature data and our own research on HSP70-dependent mechanisms of neuroprotection and discusses potential pharmacological agents that can influence HSP70 expression to improve neurological outcomes and effective therapy. The authors formed a systemic concepts of the role of HSP70-dependent mechanisms of endogenous neuroprotection aimed at stopping the formation of mitochondrial dysfunction, activation of apoptosis, desensitization of estrogen receptors, reduction of oxidative and nitrosative stress, prevention of morpho-functional changes in brain cells during cerebral ischemia, and experimentally substantiated new target links for neuroprotection. Heat shock proteins (HSPs) are an evolutionarily integral part of the functioning of all cells acting as intracellular chaperones that support cell proteostasis under normal and various stress conditions (hyperthermia, hypoxia, oxidative stress, radiation, etc.). The greatest curiosity in conditions of ischemic brain damage is the HSP70 protein, as an important component of the endogenous neuroprotection system, which, first of all, performs the function of intracellular chaperones and ensures the processes of folding, holding and transport of synthesized proteins, as well as their degradation, both under normoxic conditions and stress-induced denaturation. A direct neuroprotective effect of HSP70 has been established, which is realized through the regulation the processes of apoptosis and cell necrosis due to a long-term effect on the synthesis of antioxidant enzymes, chaperone activity, and stabilization of active enzymes. An increase in the level of HSP70 leads to the normalization of the glutathione link of the thiol-disulfide system and an increase in the resistance of cells to ischemia. HSP 70 is able to activate and regulate compensatory ATP synthesis pathways during ischemia. It was found that in response to the cerebral ischemia formation, HIF-1a is expressed, which initiates the launch of compensatory mechanisms for energy production. Subsequently, the regulation of these processes switches to HSP70, which “prolongs” the action of HIF-1a, and also independently maintains the expression of mitochondrial NAD-dependent malate dehydrogenase activity, thereby maintaining the activity of the malate-aspartate shuttle mechanism for a long time. During ischemia of organs and tissues, HSP70 performs a protective function, which is realized through increased synthesis of antioxidant enzymes, stabilization of oxidatively damaged macromolecules, and direct anti-apoptotic and mitoprotective action. Such a role of these proteins in cellular reactions during ischemia raises the question of the development of new neuroprotective agents which are able to provide modulation/protection of the genes encoding the synthesis of HSP 70 and HIF-1a proteins. Numerous studies of recent years have noted the important role of HSP70 in the implementation of the mechanisms of metabolic adaptation, neuroplasticity and neuroprotection of brain cells, so the positive modulation of the HSP70 system is a perspective concept of neuroprotection, which can improve the efficiency of the treatment of ischemic-hypoxic brain damage and be the basis for substantiating of the feasibility of using of HSP70 modulators as promising neuroprotectors.

22 November 2023 in Acta Biochimica Polonica
Verified
Journal Article
Open access
PDF file
IBIgor Belenichev
Igor Belenichev
Olena Gennadiivna AliyevaOlena Gennadiivna Aliyeva
Olena Gennadiivna Aliyeva
OPOlena Popazova
Olena Popazova
NBNina Bukhtiyarova
Nina Bukhtiyarova
Diabetes mellitus is one of the important independent risk factors for the development of neurological disorders such as ischemic stroke, transient ischemic attacks, vascular dementia and neurodegenerative processes. Hyperglycemia plays a crucial role as a trigger in the pathogenesis of these disorders. In this review, we summarize the existing data on the molecular mechanisms of diabetic encephalopathy development, consider the features of oxidative and nitrosative stresses, changes in the thiol-disulfide system, as well as mitochondrial and endothelial dysfunction in diabetes. We focus on the role of HSP 70 in cellular responses in diabetic encephalopathy. HSP70 protein is an important component of the endogenous system of neuroprotection. It acts as an intracellular chaperone, providing the folding, retention, and transport of synthesized proteins, as well as their degradation under both normoxic and stress-induced denaturation conditions. HSP70 can be considered a molecular marker and a promising therapeutic target in the treatment of diabetes mellitus.

20 March 2024 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
Olena Gennadiivna AliyevaOlena Gennadiivna Aliyeva
Olena Gennadiivna Aliyeva
IBIgor Belenichev
Igor Belenichev
NBNina Bukhtiyarova
Nina Bukhtiyarova
DSDenis Semenov
Denis Semenov
SVSergiy Voloshchuk
Sergiy Voloshchuk
Prenatal hypoxia (PH) poses a significant threat to fetal development and may be responsible for neonatal mortality or neurodevelopmental abnormalities. The proteins HSP70 and HIF-1, which hold a distinct significance in the cellular reaction to PH, can be regarded as potential targets for pharmaceutical interventions aimed at mitigating the repercussions of chronic PH. This study aimed to identify a possible correlation between offspring survival and stages of expression of endogenous neuroprotective factors (HSP70 and HIF-1) after chronic prenatal hypoxia with course administration of potential HSP70 modulators (angiolin, piracetam, thiotriazoline, nicomex, cerebrocurin, tamoxifen, L-arginine, glutoredoxin, HSF-1, and mildronate). In the rat offspring after PH we determined the plasma concentrations of HSP70 and HIF-1 by solid-phase ELISA immunoassay, and the expression of HIF-1 mRNA and HSP70 mRNA by real-time PCR. For the first time, we found a positive correlation between offspring survival after PH and the expression of HIF-1 and HSP70, both in groups without experimental therapy and in groups receiving pharmacological agents. The course administration of HSP70/HIF-1α modulators, especially angiolin (50 mg/kg), cerebrocurin (150 mg/kg), and HSF-1 (50 mg/kg), to rats that underwent PH reduces postnatal lethality, increases blood plasma concentrations of HSP70 and HIF-1α, and positively affects the expression level of HIF-1α mRNA in the rat brain. These drugs can be considered as the most promising drug candidates for new therapeutic strategies of pharmacological correction of the consequences of chronic PH.

20 February 2025 in Innovative Biosystems and Bioengineering
Verified
Journal Article
Open access
PDF file
LMLyudmyla Makyeyeva
Lyudmyla Makyeyeva
OFOleksandr Frolov
Oleksandr Frolov
Olena Gennadiivna AliyevaOlena Gennadiivna Aliyeva
Olena Gennadiivna Aliyeva
Background. Chronic stress is the most common systemic factor that negatively affects the body's overall resistance, including wound healing. While many aspects of skin recovery after a surgical wound are well defined, the involvement of cells in the periwound rarea emains unsufficiently studied. Objective. To determine the morphological features of the periwound skin at different stages of the healing process after exposure to chronic social stress. Methods. Chronic social stress was modeled through long-term psychoemotional exposure in Wistar laboratory rats of the experimental group. Animals in both control and experimental groups were wounded in the interscapular area by skin excision. The material of the periwounds was collected on the 1st, 3rd, 7th, 14th and 30th days of wound healing and processed according to standard histological methods. Results. Exposure to chronic social stress led to thinning of the skin layers even before wounding. Visual wound healing was delayed. The main reparative processes by phases (inflammation, proliferation, and remodulation) also occurred with significant delays. Conclusions. Aggressive-dominant social stress is a rather strong damaging factor for susceptible animals, leading to impaired physiological skin regeneration. This was evident in the thinning of skin layers observed in histological samples even before wound application, resulting from reduced proliferation and differentiation processes. The negative consequences of chronic social stress were further manifested in the healing of a surgical wound: the repair processes during the main phases, in particular inflammation and proliferation, were delayed, which ultimately led to the chronicity of reparative regeneration.

1 March 2023 in Medical Sciences Forum
Verified
Conference Paper
Open access
PDF file
Olena Gennadiivna AliyevaOlena Gennadiivna Aliyeva
Olena Gennadiivna Aliyeva
IBIgor Belenichev
Igor Belenichev
OPOlena Popazova
Olena Popazova
The problem of pharmacologically correcting CNS hypoxic disorders is one of priority. HSP70, an endogenous regulator of cytoprotective processes, can be considered as an effective pharmacological target. The aim of this research was to study the ability of cerebrocurin, angiolin, glutoredoxin, tamoxifen, thiotriazoline, L-arginine, nikomex, HSF-1 and piracetam to modulate the level of HSP70 in the cerebral cortex and blood plasma of rats after prenatal hypoxia (PH). We studied the effect of the drugs on the content of HSP70 in the plasma and neurons (cytoplasmic and mitochondrial fractions) of rat pups on the 30th and 60th day of life in model of chronic hemic PH using the enzyme immunoassay method. It was found that PH leads to the suppression of HSP70 synthesis and to the decrease in its intra- and extracellular levels, with the most significant decrease during the 1st month of life. Drugs course administration demonstrates an increase in intracellular and extracellular levels of HSP70 with a prolonged effect. Cerebrocurin, angiolin, and tamoxifen were the most active modulators of intracellular HSP70. Cerebrocurin, angiolin, and piracetam had the most active effect on the HSP70 content in blood plasma, but the effect of piracitam on the cytosolic and mitochondrial HSP70 fractions was the least of all the drugs studied. Here, we show that cerebrocurin and angiolin were the most effective modulators of HSP70, and their neuroprotective effect deserves further comprehensive study in order to develop methods for effective treatment of hypoxic disorders. HSP70 can serve as a target and marker of hypoxia pharmacological correction.

9 November 2022 in Biology and Life Sciences Forum
Verified
Conference Paper
Open access
PDF file
IBIgor Belenichev
Igor Belenichev
Olena Gennadiivna AliyevaOlena Gennadiivna Aliyeva
Olena Gennadiivna Aliyeva
NBNina Bukhtiyarova
Nina Bukhtiyarova
OPOlena Popazova
Olena Popazova
VRViktor P. Ryzhenko
Viktor P. Ryzhenko
The aim of this research was to analyze the neuroprotective action of drugs via an evidence-based approach to analyzing the expression of endogenous neuroprotection factors in various experimental models of cerebral ischemia in Wistar white rats (intracerebral hemorrhage, carotid artery occlusion, prenatal hypoxia) to further substantiate their use in the treatment of CNS damage. The experimental studies were carried out in accordance with the “Regulations on the Use of Animals in Biomedical Research” and the European Convention on the Protection of Animals Used for Scientific and Other Purposes. The experiment was approved by the Bioethics Committee of Zaporizhzhia State Medical University. In studies, it was found that pharmacotherapy of emerging mitochondrial disorders with modulators of HSP70 expression—Cerebrocurin (composition: neuropeptides, S-100 proteins, reelin, factor nerve growth (NGF)), Glutoredoxin, Tamoxifen, (S)-2,6-diaminohexanoic acid, 3-methyl-1,2,4-triazolyl-5-thioacetate significantly (p < 0.05) stimulates energy production in the brain. This is expressed in an increase in the content of a number of intermediates of energy metabolism (glucose, pyruvate, succinate, isocitrate, malate) in the brain tissue, as well as an increase in the activity of pentose phosphate shunt dehydrogenase. A significant (p < 0.05) decrease in the level of lactic acid in the brain indicates a decrease in the proportion of anaerobic glycolysis. The most pronounced energotropic effect was shown by cerebrocurin (150 µL/kg) and (S)-2,6-diaminohexanoic acid 3-methyl-1,2,4-triazolyl-5-thioacetate (50 mg/kg). On the 21st day of treatment of rats with cerebral ischemia, there was a gradual reduction in the severity between animals with simulated pathology and healthy rats, which is associated with actively recovering mitochondrial energy production and cerebral load in general. These changes in energy metabolism correlate with the normalization of the oxidant–antioxidant balance and the concentration of HSP70 and HSF-1a in the cytosol and mitochondria of the cerebral ischemia zone and are manifested in a significant (p < 0.05) decrease in ultrastructural disorders of mitochondria. The energy-tropic and mitoprotective effects of the studied drugs are associated with their ability to protect mitochondrial proteins from oxidative damage by increasing the concentration of HSP70, prolong the lifespan of HSF-1a, and activate alternative energy generation pathways.